2021 Innovation Discovery Grants Awarded

Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring.

Read More: https://www.massgeneralbrigham.org/newsroom/press-releases/innovation-discovery-grants-awarded-mass-general-brigham-scientific-0

Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital

Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital

Long-Lasting mRNA Therapy for Genetic Disorders, Jinjun Shi, PhD, Brigham and Women’s Hospital

AAV-Based Gene Replacement Therapy Improves Targeting and Clinical Outcomes in a Childhood CNS Disorder, Yulia Grishchuk, PhD, Massachusetts General Hospital

Towards a Permanent Genetic Cure for Spinal Muscular Atrophy, Benjamin Kleinstiver, PhD, Massachusetts General Hospital

Differentiation of Retinal Neurons for Cell Replacement in Glaucoma, Petr Baranov, MD, PhD, Massachusetts Eye and Ear

Most Recent Posts:

Blog CILP 2023 Cohort image

Meet the 2023 Commercialization and Inclusive Leadership Program Participants

Congratulations to all the participants chosen to attend the 2023 Mass General Brigham Commercialization and Inclusive Leadership…

Read More
Blog 2023 WMIF image

Connect with global leaders in healthcare innovation at the 2023 World Medical Innovation Forum June 12-14

The annual World Medical Innovation Forum is being held in person at the Westin Seaport District in…

Read More
Blog Employee Service Recognition image

Innovation Employees Celebrate Years of Service Milestones

More than 500 Mass General Brigham employees were honored in the recent 26th annual Enterprise Services Employee…

Read More